European urology

Patient-reported Outcomes for Patients with Metastatic Castration-resistant Prostate Cancer and BRCA1/2 Gene Alterations: Final Analysis from the Randomized Phase 3 MAGNITUDE Trial.

Pub Date : 2024-09-23 DOI: 10.1016/j.eururo.2024.09.003 Dana E Rathkopf, Guilhem Roubaud, Kim N Chi, Eleni Efstathiou, Gerhardt Attard, David Olmos, Eric J Small, Marniza Saad, Elena Castro, Won Kim, Daphne Wu, Kristi Bertzos, Shiva Dibaj, Jenny Zhang, Peter Francis, Matthew R Smith

Impact of Prior Chemotherapy on Response to Second-line Pembrolizumab in Urothelial Cancer: Exploratory Analysis of the Phase 3 KEYNOTE-045 Trial.

Pub Date : 2024-08-21 DOI: 10.1016/j.eururo.2024.07.015 Ronald de Wit, David J Vaughn, Yves Fradet, Lawrence Fong, Miguel A Climent, Andrea Necchi, Daniel P Petrylak, Winald R Gerritsen, Howard Gurney, David I Quinn, Stéphane Culine, Cora N Sternberg, Dean F Bajorin, Toni K Choueiri, Jin Xu, Kentaro Imai, Blanca Homet Moreno, Joaquim Bellmunt, Jae-Lyun Lee

Re: External Validation of the Rotterdam Prostate Cancer Risk Calculator and Comparison with Stockholm3 for Prostate Cancer Diagnosis in a Swedish Population-based Screening Cohort.

Pub Date : 2024-08-01 DOI: 10.1016/j.eururo.2024.05.002 Christian D Fankhauser, Marian S Wettstein, Christoph Würnschimmel, Maarten van Smeden, Noel W Clarke